Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Regorafenib Versus Placebo to Treat Cholangiocarcinoma (REACHIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02162914
Recruitment Status : Active, not recruiting
First Posted : June 13, 2014
Last Update Posted : March 20, 2019
Sponsor:
Information provided by (Responsible Party):
Erasme University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 2019
Estimated Study Completion Date : June 2020